After investigation or testing by the Division of the content or composition of any drug, medicine, compound or device used by any person or association in the diagnosis, treatment or cure of cancer, the Division may direct that such person or association cease and desist any further prescribing, recommending or use of any such drug, medicine, compound or device or substantially similar drugs, medicines, compounds or devices in the diagnosis or treatment of cancer.
(Added to NRS by 1960, 64; A 1977, 1222)